Transform healthcare by integrating expertise from AI, clinical sciences, and basic sciences to harness India’s extensive data sets for improving the access to healthcare
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
A committee to be formed to suggest measures for ensuring the safety of healthcare professionals
The emergence of new infections in India is a growing concern
India Business grew by 11.9% YoY to Rs. 1196.2 crore
European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
